Imugene (IMU) Stock Statistics & Valuation Metrics

Imugene has a market cap or net worth of $82.40M. The enterprise value is AU$63.39M.

Imugene has 219,728,300 shares outstanding. The number of shares has decreased by -2.65% in one year.

Imugene’s return on equity (ROE) is -1.27 and return on invested capital (ROIC) is -111.14%.

The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.

In the last 12 months, Imugene had revenue of 10.81M and earned -149.68M in profits. Earnings per share was -0.02.

In the last 12 months, operating cash flow was -87.52M and capital expenditures -8.72M, giving a free cash flow of -96.24M billion.

Imugene pays an annual dividend of ―, resulting in a dividend yield of ―

Imugene upcoming earnings date is Aug 27, 2025, TBA (Confirmed).

Imugene as a current ratio of 3.86, with Debt / Equity ratio of 24.90%

In the past 12 months, Imugene has paid -4.62M in taxes.

Imugene EV to EBITDA ratio is -2.02, with an EV/FCF ratio of -2.79.

Imugene has $33.74M in cash and marketable securities with AU$15.76M in debt, giving a net cash position of -$17.99M billion.

Gross margin is 100.00%, with operating margin of -1303.72%, and net profit margin of -1384.66%.

The average price target for Imugene is ―, which is 11.43% higher than the current price. The consensus rating is Moderate Sell